MYC and cancer: Interestingly, c-Myc promotes p53 polyubiquitination and turnover by reducing p53 SUMOylation through c-Myc-inducible LncRNA inactivating P53 (MILIP), driving cancer pathogenesis (Feng et al., 2020).